Management of Peritoneal Surface Malignancies in Saudi Arabia: An Update.

Autor: Helmi H; Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alyami M; Department of Surgery, King Khalid Hospital, Najran, Saudi Arabia., Bin Traiki T; Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Amin T; Department of Surgical Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Alzahrani A; Department of Surgical Oncology, King Abdullah Medical City, Makkah, Saudi Arabia., Alnahawi M; Department of Surgery, Almoosa Specialist Hospital, Alhasa, Saudi Arabia., Alzahrani N; Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Jazyk: angličtina
Zdroj: Journal of surgical oncology [J Surg Oncol] 2024 Sep 10. Date of Electronic Publication: 2024 Sep 10.
DOI: 10.1002/jso.27879
Abstrakt: Peritoneal surface malignancies (PSM) are aggressive and associated with poor prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used to treat PSM since 1990. In Saudi Arabia, the first HIPEC and pressurized intraperitoneal aerosol chemotherapy (PIPAC) were performed in 2008 and 2019, respectively. With increasing incidences of PSM in Saudi Arabia, the demand for such procedures has grown. This article outlines the status of PSM management in Saudi Arabia and its prospects.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: